Cat.#: ACPP-1750
Despition | LCN1 Human Recombinant |
SIZE | 5 µg |
Purity | > 90.0% (SDS-PAGE) |
Form | Sterile Filtered colorless solution. |
Storage | Store at 4°C for 2-4 weeks. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1351 | Dopamine D2 Receptor Blocking Peptide (AC1351) | 250 µg | inquiry |
ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
ACPP-1693 | Human CDK1 Protein (AC1693) | 5 µg | inquiry |
ACPP-1297 | p75 NGF Receptor Blocking Peptide (AC1297) | 250 µg | inquiry |
ACPP-1402 | Mouse CDNF Protein (AC1402) | 5 µg | inquiry |
ACPP-1329 | PDE6 Beta Blocking Peptide (AC1329) | 250 µg | inquiry |
ACPP-1025 | Recombinant Human GPR56 Protein (6×His Tag) (AC1025) | 50 µg | inquiry |
ACPP-1092 | Synthetic Nanodisc Human GLP-1R Protein (AC1092) | 10 µg | inquiry |
ACPP-1048 | Recombinant Human Butyrylcholinesterase Protein (6×His Tag) (AC1048) | 50 µg | inquiry |
ACPP-1488 | Mouse CNTF Protein (AC1488) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.